Environment
Resilient and sustainable operations
We operate responsibly at the center of the human and animal health pharmaceutical supply chain, enabling the safe, efficient, and responsible delivery of lifesaving medications and healthcare services.
Watch Our Purpose in action: Resilient and sustainable operations to see how Cencora puts corporate responsibility into practice — advancing responsible, resilient operations that support reliable healthcare delivery.
Available in English only.
We bring innovation and efficiency to the supply chain
We operate at the center of the human and animal health pharmaceutical supply chain, enabling the safe, efficient, and responsible delivery of lifesaving medications and healthcare services. To strengthen business continuity, we prioritize resilience by implementing advanced forecasting systems, equipping facilities with backup power sources, and conducting regular emergency preparedness training to mitigate the impact of severe weather on our operations.
Guided by our commitment to operating sustainably, we invest in innovative solutions for our buildings, product packaging, and transportation, collaborating with partners to amplify our impact. We align our corporate responsibility reporting with leading global frameworks.
Progress on our Science-Based Targets
Product integrity and patient safety
Supplier Engagement and Resiliency
Salud y seguridad de los miembros del equipo
Preparación para emergencias y respuesta ante desastres
Ciberseguridad, protección de datos y privacidad
Helping combat the opioid addiction
Cencora’s wholesale pharmaceutical distribution business plays a key, but specific, role of providing safe access to thousands of important medications to enable healthcare providers to serve patients with a wide array of clinical needs across the healthcare spectrum. A small part of this includes the distribution of opioids and other controlled substances from manufacturers to neighborhood pharmacies and pharmacy chains, as well as to hospitals, nursing homes, hospices, and other clinical settings. As opioid addiction continues to impact patients and families, we are taking a proactive, collaborative approach to help combat opioid misuse and abuse while also seeking to ensure access for patients with legitimate medical needs.
We have taken substantial steps to help prevent the diversion of controlled substances. Cencora has a sophisticated diversion control program through which the Company provides daily reports to the United States Drug Enforcement Administration about the quantity, type, and receiving pharmacy of every order of controlled substances that we distribute. We also work closely with other healthcare stakeholders, government entities, civic organizations, law enforcement agencies, individuals our nonprofit partners to support prescription drug safety and mental health resources in local communities. We continuously evaluate, enhance, strengthen and expand the proven measures that we have implemented to maintain the integrity of every order we ship.
Distributors such as Cencora do not manufacture or create supply or demand for opioids. The distribution of opioid medicines represents less than one percent of our annual revenue, and we do not offer our sales team members incentives based on opioid sales.
More details on our efforts to ensure safe and secure distribution, maintain operational integrity, and support legislation can be found in our periodic reports filed with the U.S. Securities and Exchange Commission at www.sec.gov and on the investor relations section of our website at investor.cencora.com/overview/default.aspx
